Human Investing’s Exelon EXC Stock Holding History

Human Investing’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-398	Closed	-$12K	–	168
2021 Q1	$12K	Hold	398	–	–	﹤0.01%	226
2020 Q4	$12K	Hold	398	–	–	﹤0.01%	220
2020 Q3	$10K	Hold	398	–	–	﹤0.01%	226
2020 Q2	$10K	Buy	+398	New	+$10.6K	﹤0.01%	222
2019 Q1	–	Sell	-196	Closed	-$6K	–	365
2018 Q4	$6K	Buy	+196	New	+$6.27K	﹤0.01%	297

Other funds holding EXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Human Investing's EXC Position: Q2 2021 in Review

Human Investing sold out of Exelon (EXC) in Q2 2021, closing a stake of 398 shares — an estimated $12K sold.

Human Investing first reported a position in EXC in Q4 2018 and held it in 5 quarters. The position peaked at $12K in Q1 2021. 918 funds tracked by Wall St. Rank hold EXC as of Q2 2021.

Human Investing reported no remaining Exelon position as of Q2 2021 after selling out during the quarter.
Human Investing sold 398 Exelon shares in Q2 2021, an estimated $12K.
Human Investing first reported a position in Exelon in Q4 2018 and held it in 5 quarters.
Human Investing's Exelon position peaked at $12K in Q1 2021.
918 funds tracked by Wall St. Rank held Exelon as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.